Bleomycin-detectable iron in serum from leukaemic patients before and after chemotherapy. Therapeutic implications for treatment with oxidant-generating drugs

scientific article published on 01 December 1988

Bleomycin-detectable iron in serum from leukaemic patients before and after chemotherapy. Therapeutic implications for treatment with oxidant-generating drugs is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0014-5793(88)81061-5
P698PubMed publication ID2461877

P2093author name stringHalliwell B
Aruoma OI
Bomford A
Mufti G
P433issue1-2
P407language of work or nameEnglishQ1860
P921main subjectchemotherapyQ974135
P304page(s)202-204
P577publication date1988-12-01
P1433published inFEBS LettersQ1388051
P1476titleBleomycin-detectable iron in serum from leukaemic patients before and after chemotherapy. Therapeutic implications for treatment with oxidant-generating drugs
P478volume241

Reverse relations

cites work (P2860)
Q70931675'Free' iron, as detected by electron paramagnetic resonance spectroscopy, increases unequally in different tissues during dietary iron overload in the rat
Q73443855Apotransferrin administration prevents growth of Staphylococcus epidermidis in serum of stem cell transplant patients by binding of free iron
Q41498479Ascorbic-acid-mediated iron release from cellular ferritin and its relation to the formation of DNA strand breaks in neuroblastoma cells.
Q67540643Bleomycin-reactive iron in patients with acute non-lymphocytic leukemia
Q41154272Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system
Q38801048Catalytic iron and acute kidney injury.
Q36711411Drug antioxidant effects. A basis for drug selection?
Q47894480Erratum to "Apotransferrin administration prevents growth of Staphylococcus epidermidis in serum of stem cell transplant patients by binding of free iron". [FEMS Immunol. Med Microbiol. 37 (2003) 45-51].
Q41648536Free radicals and antioxidants in chemotherapy-induced toxicity
Q36089796Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis
Q38198634Labile iron in cells and body fluids: physiology, pathology, and pharmacology
Q71630063Measurement of iron and copper in biological systems: bleomycin and copper-phenanthroline assays
Q41514599No enzymatic activities are necessary for the stabilization of ascorbic acid by K-562 cells
Q36336362Non transferrin bound iron: nature, manifestations and analytical approaches for estimation
Q37248962Non-transferrin bound iron and neutropenia after cytotoxic chemotherapy
Q73212248Nontransferrin-bound iron in serum of patients receiving bone marrow transplants
Q37833060Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments
Q60619557Prevalence of hemochromatosis related HFE gene mutations in patients with acute myeloid leukemia
Q37224329Role of non-transferrin bound iron in iron overload and liver dysfunction in long term survivors of acute leukaemia and bone marrow transplantation
Q35336409Roles of iron in neoplasia. Promotion, prevention, and therapy
Q35852267Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress
Q42800114Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions
Q69566200Tell me about free radicals, doctor: a review
Q38496987The Labile Side of Iron Supplementation in CKD
Q34094818The importance of non-transferrin bound iron in disorders of iron metabolism
Q36571701Transient iron overload with bleomycin detectable iron in the plasma of patients with adult respiratory distress syndrome
Q73703028Unexpected effects of albumin on apoptosis induction by deferoxamine in vitro

Search more.